Teleflex Appoints Jason Weidman as President and CEO

May 6, 2026—Teleflex Incorporated announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8, 2026. Weidman is expected to join the Teleflex Board when he assumes his role as President and CEO.

According to Teleflex, Weidman joins the company from Medtronic, where he held senior leadership roles since 2006. Most recently he served as Senior Vice President and President, Coronary & Renal Denervation, and Senior Vice President and President, Aortic, Peripheral and Venous. In these positions, he oversaw significant growth and global expansion of multibillion dollar revenue operating units, including the launch of key innovations and acquisitions.

“It’s an honor for me to join Teleflex at such an important inflection point and to help lead the company into its next phase of growth,” commented Weidman in the Teleflex press release. “Having spent my entire career in the medical technology industry, I see a clear opportunity for Teleflex to build on its strong foundation and commitment to innovation, further shaping the future of health care while advancing our purpose of improving the health and quality of people’s lives.”

Teleflex’s Chairman of the Board, Stephen Klasko, MD, stated in the press release, “We’re thrilled to welcome Jason to Teleflex. Following the completion of the divestitures, Teleflex will be a fundamentally transformed company, with a portfolio focused on our core interventional, critical care, and high acuity hospital markets.”